Center For Scientific Review; Notice of Closed Meetings, 2968-2969 [2024-00754]
Download as PDF
<![CDATA[
2968
Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC–SBIR PHS
2024–1 Phase I: Adjuvant Development for
Vaccines for Infectious and ImmuneMediated Diseases (Topic 128).
Date: February 8–9, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Michael M. Opata, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G22, Rockville, MD
20852, 240–627–3319, michael.opata@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00774 Filed 1–16–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Surgery,
Anesthesiology and Trauma Study Section.
Date: February 7–8, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:14 Jan 16, 2024
Jkt 262001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Pathophysiological Basis of Mental
Disorders and Addictions Study Section.
Date: February 7–8, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Boris P. Sokolov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A,
MSC 7846, Bethesda, MD 20892, 301–408–
9115, bsokolov@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Imaging Probes and
Contrast Agents Study Section.
Date: February 8–9, 2024.
Time: 7:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree McLean Tysons, 1960
Chain Bridge Road, McLean, VA 22101.
Contact Person: Donald Scott Wright,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
8363, wrightds@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Macromolecular Structure
and Function C Study Section.
Date: February 8–9, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Guillermo Andres
Bermejo, Ph.D., Scientific Review Officer,
The Center for Scientific Review, The
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 827–5742,
bermejog@mail.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Mechanisms of Cancer Therapeutics
B Study Section.
Date: February 8–9, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6705 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Dolores Arjona
Mayor, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 806D, Bethesda, MD 20892, (301) 827–
8578, dolores.arjonamayor@nih.gov.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Sensory-Motor
Neuroscience Study Section.
Date: February 8–9, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency, Bethesda One,
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Alena Valeryevna
Savonenko, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 1009J, Bethesda, MD 20892, (301) 594–
3444, savonenkoa2@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Basic
Mechanisms of Diabetes and Metabolism
Study Section.
Date: February 8–9, 2024.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites—Old Town
Alexandri,a Hilton Alexandria Old Town, VA
22314.
Contact Person: Baskaran Thyagarajan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 800B,
Bethesda, MD 20892, (301) 594–0331,
BASKI.THYAGARAJAN@NIH.GOV,
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Language and Communication Study
Section.
Date: February 8–9, 2024.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle NW, Washington, DC 20005.
Contact Person: Rochelle Francine
Hentges, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 1000C, Bethesda, MD 20892, (301)
402–8720, hentgesrf@mail.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Kidney Endocrine and Digestive Disorders
Study Section.
Date: February 8–9, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Steven M. Frenk, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3141,
Bethesda, MD 20892, (301) 480–8665,
frenksm@mail.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Atherosclerosis and Vascular Inflammation
Study Section.
Date: February 8–9, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\17JAN1.SGM
17JAN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Natalia Komissarova,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, (301) 435–
1206, komissar@mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Clinical Informatics and Digital Health Study
Section.
Date: February 8–9, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paul Hewett, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room,
Bethesda, MD 20892, (240) 672–8946,
hewettmarxpn@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Drug and Biologic Disposition and Toxicity
Study Section.
Date: February 8–9, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Hilton Garden Inn, Washington
DC/Georgetown, 2201 M Street NW,
Washington, DC 20037.
Contact Person: Stacey Nicole Williams,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, stacey.williams@
nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Interdisciplinary Clinical Care in Specialty
Care Settings Study Section.
Date: February 8–9, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Abu Saleh Mohammad
Abdullah, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 827–4043,
abuabdullah.abdullah@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00754 Filed 1–16–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:14 Jan 16, 2024
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Treatment; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Treatment
(CSAT) National Advisory Council
(NAC) will meet on February 27, 2024,
9:00 a.m.–4:30 p.m. (EST).
The meeting is open to the public and
will include consideration of minutes
from the SAMHSA CSAT NAC meeting
of August 29, 2023, a discussion with
SAMHSA leadership, a discussion on
housing and homelessness, a discussion
on the activities of the
Interdepartmental Substance Use
Disorders Coordinating Committee, and
a discussion on the following CSAT
programs, the Minority Fellowship
Program, the Center of Excellence, and
Historically Black Colleges and
Universities Center of Excellence in
Behavioral Health. This meeting will
also cover updates on CSAT activities
from the Office of the Director; the
Division of Pharmacologic Therapies;
the Division of States and Community
Systems; the Division of Services
Improvement; Office of Program
Analysis and Coordination; Office of
Performance Analysis and Management.
The meeting will be held at SAMHSA,
5600 Fishers Lane, 5N76, Rockville, MD
20857. Attendance by the public will be
limited to space available and will be
limited to the open sessions of the
meeting. Interested persons may present
data, information, or views, orally or in
writing, on issues pending before the
Council. Presentations from the public
will be scheduled at the conclusion of
the meeting. Individuals interested in
making oral presentations must notify
the contact person, Tracy Goss, CSAT
NAC Designated Federal Officer (DFO)
on or before February 16, 2024. Up two
minutes will be allotted for each
approved public comment as time
permits. Written comments received in
advance of the meeting will be
considered for inclusion in the official
record.
The open meeting session may also be
accessed virtually. Please register online at https://snacregister.samhsa.gov,
to attend on either on site or virtually,
submit written or brief oral comments,
or request special accommodations for
persons with disabilities. To
communicate with the CSAT NAC DFO
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
2969
please see the contract information
below.
Meeting information and a roster of
Council members may be obtained by
accessing the SAMHSA Committee
website at https://www.samhsa.gov/
about-us/advisory-councils/csatnational-advisory-council, or by
contacting the DFO.
Council Name: SAMHSA’s Center for
Substance Abuse Treatment National
Advisory Council.
Date/Time/Type: August 29, 2023,
9:00 a.m.–4:30 p.m. EST, OPEN.
Place: SAMHSA, 5600 Fishers Lane,
Rockville, Maryland 20857.
Contact: Tracy Goss, Designated
Federal Officer, CSAT National
Advisory Council, 5600 Fishers Lane,
Rockville, Maryland 20857 (mail),
Telephone: (240) 276–0759, Email:
tracy.goss@samhsa.hhs.gov.
Dated: January 10, 2024.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2024–00746 Filed 1–16–24; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Meeting of the Substance Abuse and
Mental Health Services Administration,
Center for Mental Health Services
National Advisory Council
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
Pursuant to Public Law 92–
463, notice is hereby given of the
meeting on February 27, 2024, of the
Substance Abuse and Mental Health
Services Administration (SAMHSA),
Center for Mental Health Services
National Advisory Council (CMHS
NAC).
The meeting is open to the public and
will include consideration of the
meeting minutes from the August 29,
2023, SAMHSA, CMHS NAC meeting;
updates from the CMHS Director;
remarks from SAMHSA’s Assistant
Secretary; updates on Statewide
Consumer Network Grants; updates on
Subcommittee Tasks; Legislative
updates; and Tribal updates. Agenda
with call-in information will be posted
on the SAMHSA website prior to the
meeting at: https://www.samhsa.gov/
about-us/advisory-councils/meetings.
The meeting will be held at SAMHSA,
5600 Fishers Lane, 5W11, Rockville, MD
20857. Attendance by the public will be
SUMMARY:
E:\FR\FM\17JAN1.SGM
17JAN1
]]>Agencies
[Federal Register Volume 89, Number 11 (Wednesday, January 17, 2024)]
[Notices]
[Pages 2968-2969]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00754]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Surgery, Anesthesiology and
Trauma Study Section.
Date: February 7-8, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD
20892, (301) 435-1170, [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Pathophysiological Basis of Mental
Disorders and Addictions Study Section.
Date: February 7-8, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Boris P. Sokolov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD
20892, 301-408-9115, [email protected].
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Imaging Probes and Contrast
Agents Study Section.
Date: February 8-9, 2024.
Time: 7:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: DoubleTree McLean Tysons, 1960 Chain Bridge Road, McLean,
VA 22101.
Contact Person: Donald Scott Wright, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD
20892, (301) 435-8363, [email protected].
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group; Macromolecular Structure and
Function C Study Section.
Date: February 8-9, 2024.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Guillermo Andres Bermejo, Ph.D., Scientific
Review Officer, The Center for Scientific Review, The National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892,
(301) 827-5742, [email protected].
Name of Committee: Biology of Development and Aging Integrated
Review Group; Mechanisms of Cancer Therapeutics B Study Section.
Date: February 8-9, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria Dolores Arjona Mayor, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 806D, Bethesda, MD 20892, (301)
827-8578, [email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Sensory-Motor Neuroscience
Study Section.
Date: February 8-9, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency, Bethesda One, Bethesda Metro Center,
Bethesda, MD 20814.
Contact Person: Alena Valeryevna Savonenko, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301)
594-3444, [email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Basic Mechanisms of
Diabetes and Metabolism Study Section.
Date: February 8-9, 2024.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites--Old Town Alexandri,a Hilton Alexandria
Old Town, VA 22314.
Contact Person: Baskaran Thyagarajan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 800B, Bethesda, MD 20892, (301)
594-0331, [email protected],
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Language and Communication Study Section.
Date: February 8-9, 2024.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Plaza Hotel, 10 Thomas Circle NW, Washington,
DC 20005.
Contact Person: Rochelle Francine Hentges, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000C, Bethesda, MD 20892, (301)
402-8720, [email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Kidney Endocrine and Digestive Disorders
Study Section.
Date: February 8-9, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Steven M. Frenk, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3141, Bethesda, MD 20892, (301)
480-8665, [email protected].
Name of Committee: Vascular and Hematology Integrated Review
Group; Atherosclerosis and Vascular Inflammation Study Section.
Date: February 8-9, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 2969]]
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Natalia Komissarova, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD
20892, (301) 435-1206, [email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Clinical Informatics and Digital Health
Study Section.
Date: February 8-9, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paul Hewett, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institute of Health, 6701
Rockledge Drive, Room, Bethesda, MD 20892, (240) 672-8946,
[email protected].
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Drug and Biologic Disposition and Toxicity
Study Section.
Date: February 8-9, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Hilton Garden Inn, Washington DC/Georgetown, 2201 M
Street NW, Washington, DC 20037.
Contact Person: Stacey Nicole Williams, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Interdisciplinary Clinical Care in
Specialty Care Settings Study Section.
Date: February 8-9, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Abu Saleh Mohammad Abdullah, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827-4043,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00754 Filed 1-16-24; 8:45 am]
BILLING CODE 4140-01-P
